Study of MultI-eLectrode EndovaScular denervaTiOn in patieNts with type 2 diabetes mEllitus (MILESTONE): 6-month analysis from the first-in-human proof-of-concept study

被引：0
|
作者：
Pan, T. [1 ]
Wang, Z. [1 ]
Teng, G. -J. [1 ]
机构：
[1] Southeast Univ, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
102
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] Procedure Safety From First-in-Human Study of Duodenal Mucosal Resurfacing as a New Endoscopic Treatment for Type 2 Diabetes
    Neto, Manoel Galvao
    Coad, James E.
    Becerra, Pablo
    Rodriguez, Patricia
    Thompson, Christopher C.
    Rubenstein, J. Nicholas
    Beatty, Colleen
    Rodriguez, Leonardo
    GASTROENTEROLOGY, 2016, 150 (04) : S233 - S233
  • [32] Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study
    Shah, S.
    Benroubi, M.
    Borzi, V.
    Gumprecht, J.
    Kawamori, R.
    Shaban, J.
    Shestakova, M.
    Wenying, Y.
    Valensi, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 574 - 582
  • [33] Effectiveness of the switch from insulin to incretin therapy in patients with long-lasting type 2 diabetes: a 6-month longitudinal, real-life study
    Citarrella, R.
    Di Vittorio, M.
    Bonfiglio, A.
    Speciale, S.
    Ruggirello, D.
    Castellino, G.
    Chianetta, R.
    Nikolic, D.
    Mannina, C.
    Montalto, G.
    DIABETOLOGIA, 2018, 61 : S363 - S363
  • [34] ABBV-3373-A NOVEL IMMUNOLOGY ANTIBODY DRUG CONJUGATE: RESULTS FROM A FIRST-IN-HUMAN SINGLE ASCENDING DOSE STUDY IN HEALTHY SUBJECTS TO SUPPORT DOSE SELECTION FOR THE PROOF-OF-CONCEPT STUDY IN RHEUMATOID ARTHRITIS PATIENTS.
    D'Cunha, R.
    Kupper, H.
    Arikan, D.
    Zhao, W.
    Ruzek, M.
    Kang, B.
    Doelger, E.
    Carter, D.
    Pang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S78 - S79
  • [35] A Retrospective Study of 6-Month Reduction in Risk of Developing Cardiovascular Diseases and Type 2 Diabetes Mellitus in Severely Obese Patients Over 60 Years of Age Following Bariatric Surgery
    Domienik-Karlowicz, Justyna
    Ziemianski, Pawel
    Malkowski, Piotr
    Kosieradzki, Maciej
    Pruszczyk, Piotr
    Lisik, Wojciech
    MEDICAL SCIENCE MONITOR, 2019, 25 : 2577 - 2582
  • [36] INFLUENCE OF PSYCHOLOGICAL FACTORS ON CALORIE INTAKE IN NATURAL SETTINGS IN TYPE 2 DIABETES PATIENTS: A 6-MONTH COMPUTERIZED ECOLOGICAL MOMENTARY ASSESSMENT STUDY
    Yoshiuchi, Kazuhiro
    Inada, Shuji
    Kikuchi, Hiroe
    Ohashi, Ken
    Iizuka, Yoko
    Takimoto, Yoshiyuki
    Yamamoto, Yoshiharu
    Kadowaki, Takashi
    Akabayashi, Akira
    PSYCHOSOMATIC MEDICINE, 2013, 75 (03): : A115 - A115
  • [37] Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Shin, Juyoung
    Chang, Jin-Sun
    Kim, Hun-Sung
    Ko, Sun-Hee
    Cha, Bong-Yun
    Son, Ho-Young
    Yoon, Kun-Ho
    Cho, Jae-Hyoung
    DIABETES & METABOLISM JOURNAL, 2012, 36 (05) : 364 - 370
  • [38] PERCUTANEOUS SYMPATHETIC RENAL DENERVATION IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: RESULTS FROM THE ENLIGHTN™ I, FIRST-IN-HUMAN MULTI-CENTER STUDY
    Papademetriou, Vasilios
    Tsioufis, Costas
    Worthley, Matthew
    Chew, Derek
    Meredith, Ian
    Malaiapan, Yuvaraj
    Sinhal, Ajay
    Worthley, Stephen G.
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (07): : 516 - 517
  • [39] SAFETY AND PERFORMANCE OF THE NEXT GENERATION ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG- RESISTANT HYPERTENSION: 18-MONTH RESULTS FROM A FIRST-IN-HUMAN STUDY
    Worthley, S.
    Wilkins, G.
    Webster, M.
    Montarello, J.
    Antonis, P.
    Whitbourn, R.
    Warren, R.
    JOURNAL OF HYPERTENSION, 2015, 33 : E359 - E359
  • [40] Results from a 12-week proof-of-concept study of a novel oral non-peptide GLP-1 receptor agonist in patients with type 2 diabetes
    Pratt, E.
    Ma, X.
    Liu, R.
    Robins, D.
    Sloop, K.
    Haupt, A.
    Benson, C.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S301 - S301
12345